Salidroside inhibits proliferation of gastric cancer cells by regulating the miR-1343-3p-OGDHL/PDHB glucose metabolic axis
HOU Xinrui
ZHANG Zhendong
CAO Mingyuan
DU Yuxin
WANG Xiaoping
Abstract:Objective To investigate the mechanism through which salidroside inhibits proliferation of gastric cancer(GC)cells focusing on glucose metabolic reprogramming pathways.Methods High-throughput sequencing combined with bioinformatics analysis was employed to identify the potential targets of salidroside in human GC MGC-803 cells.Liposome-mediated transfection experiments were carried out to validate the functional and mechanistic roles of these targets.CCK-8 and colony formation assays were used to assess the effects of salidroside on GC cell viability and clonogenic ability.qRT-PCR,Western blotting,and biochemical assay kits were used to analyze the regulatory effects of salidroside on the miR-1343-3p-OGDHL/PDHB enzyme complex-pyruvate metabolic pathway in GC cells.Results Bioinformatics analysis suggested that the tumor-suppressive factor miR-1343-3p negatively regulated the key glycolytic enzyme gene oxoglutarate dehydrogenase-like(OGDHL)in GC cells,and OGDHL and pyruvate dehydrogenase E1 subunit beta(PDHB)were both significantly upregulated in GC tissues,which was close by correlated with reduced survival rates of GC patients.In MGC-803 cells,salidroside treatment significantly enhanced the expression level of miR-1343-3p and downregulated OGDHL expression,resulting in disruption of the stability of PDHB,reduced pyruvate oxidative decarboxylation,and consequently decreased production of acetyl-CoA and ATP.Conclusion Salidroside inhibits GC cell proliferation possibly by regulating the miR-1343-3p-OGDHL/PDHB enzyme complex-pyruvate metabolic pathway,which provides new insights into its anti-tumor mechanisms and suggests new strategies for targeted therapy for GC.
Keywords:gastric cancerglucose metabolic reprogrammingsalidrosidemiR-1343-3poxoglutarate dehydrogenase-likepyruvate dehydrogenase E1 subunit beta
Publication Date:2025-06-20
Online Publishing Date:2025-08-15(First online date of this platform, not the publication date of the document)
Pages:14( 1226-1239 )
